Richard E. Showalter

2.9k total citations · 2 hit papers
29 papers, 2.1k citations indexed

About

Richard E. Showalter is a scholar working on Molecular Biology, Organic Chemistry and Immunology. According to data from OpenAlex, Richard E. Showalter has authored 29 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 6 papers in Organic Chemistry and 6 papers in Immunology. Recurrent topics in Richard E. Showalter's work include Signaling Pathways in Disease (9 papers), Hepatitis C virus research (6 papers) and bioluminescence and chemiluminescence research (4 papers). Richard E. Showalter is often cited by papers focused on Signaling Pathways in Disease (9 papers), Hepatitis C virus research (6 papers) and bioluminescence and chemiluminescence research (4 papers). Richard E. Showalter collaborates with scholars based in United States and Japan. Richard E. Showalter's co-authors include M. Silverman, Bonnie L. Bassler, J. Ernest Villafranca, Laura A. Pelletier, Mark O. Martin, Charles R. Kissinger, Hans E. Parge, Kathleen D. Tucker, Ellen W. Moomaw and Anna Tempczyk and has published in prestigious journals such as Nature, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Richard E. Showalter

29 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Crystal structures of human calcineurin and the human FKBP12–FK506–calcineurin complex

1995 630 citations Charles R. Kissinger, Hans E. Parge et al. Nature profile →
Intercellular signalling in Vibrio harveyi: sequence and function of genes regulating expression of luminescence

1993 603 citations Bonnie L. Bassler, Richard E. Showalter et al. Molecular Microbiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Richard E. Showalter United States	18	1.7k	387	363	307	217	29	2.1k
Lichuan Gu China	29	2.1k 1.3×	189 0.5×	421 1.2×	251 0.8×	105 0.5×	105	3.3k
Guillaume Charron Canada	27	1.9k 1.1×	110 0.3×	252 0.7×	338 1.1×	529 2.4×	47	2.9k
Uhn‐Soo Cho United States	22	1.9k 1.1×	160 0.4×	333 0.9×	225 0.7×	49 0.2×	41	2.5k
Roman P. Jakob Switzerland	26	1.2k 0.7×	171 0.4×	259 0.7×	107 0.3×	244 1.1×	61	1.8k
T. Krojer United Kingdom	31	2.3k 1.3×	148 0.4×	457 1.3×	270 0.9×	161 0.7×	57	3.1k
Toni Kline United States	25	908 0.5×	116 0.3×	200 0.6×	371 1.2×	354 1.6×	48	1.8k
F. Forouhar United States	33	2.0k 1.2×	73 0.2×	247 0.7×	191 0.6×	166 0.8×	67	2.9k
J.M. Sauder United States	25	1.7k 1.0×	425 1.1×	291 0.8×	143 0.5×	48 0.2×	52	2.4k
Michel Jaquinod France	32	2.1k 1.3×	63 0.2×	486 1.3×	249 0.8×	86 0.4×	77	3.2k
Jesús García Spain	23	1.3k 0.8×	181 0.5×	419 1.2×	132 0.4×	606 2.8×	61	2.2k

Countries citing papers authored by Richard E. Showalter

Since Specialization

Citations

This map shows the geographic impact of Richard E. Showalter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard E. Showalter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard E. Showalter more than expected).

Fields of papers citing papers by Richard E. Showalter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard E. Showalter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard E. Showalter. The network helps show where Richard E. Showalter may publish in the future.

Co-authorship network of co-authors of Richard E. Showalter

This figure shows the co-authorship network connecting the top 25 collaborators of Richard E. Showalter. A scholar is included among the top collaborators of Richard E. Showalter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard E. Showalter. Richard E. Showalter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Katherine, Eleanor Dagostino, Mario Meng-Chiang Kuo, et al.. (2018). TRAIL stabilization and cancer cell sensitization to its pro-apoptotic activity achieved through genetic fusion with arginine deiminase. Oncotarget. 9(97). 36914–36928. 18 indexed citations

Thompson, Peggy A., Richard E. Showalter, Rupal Patel, & James R. Appleman. (2010). In Vitro Combination of ANA598 with Other Anti-HCV Agents can Eliminate the Emergence of Resistant Colonies. Antiviral Research. 86(1). A48–A48. 1 indexed citations

Thompson, Peggy A., Shaohui Wang, Meimei Wang, et al.. (2008). Identification of Ligand Binding by Protein Stabilization: Comparison of ATLAS with Biophysical and Enzymatic Methods. Assay and Drug Development Technologies. 6(1). 69–81. 12 indexed citations

Ruebsam, Frank, Zhongxiang Sun, Benjamin K. Ayida, et al.. (2008). Hexahydro-pyrrolo- and hexahydro-1H-pyrido[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymerase. Bioorganic & Medicinal Chemistry Letters. 18(18). 5002–5005. 10 indexed citations

Dragovich, Peter S., David A. Ellis, Qing Han, et al.. (2008). Novel HCV NS5B polymerase inhibitors derived from 4-(1′,1′-dioxo-1′,4′-dihydro-1′λ6-benzo[1′,2′,4′]thiadiazin-3′-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 5: Exploration of pyridazinones containing 6-amino-substituents. Bioorganic & Medicinal Chemistry Letters. 18(20). 5635–5639. 20 indexed citations

Zhou, Yuefen, Lian‐Sheng Li, Peter S. Dragovich, et al.. (2008). Novel HCV NS5B polymerase inhibitors derived from 4-(1′,1′-dioxo-1′,4′-dihydro-1′λ6-benzo[1′,2′,4′]thiadiazin-3′-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 2: Variation of the 2- and 6-pyridazinone substituents. Bioorganic & Medicinal Chemistry Letters. 18(4). 1419–1424. 18 indexed citations

Zhou, Yuefen, Stephen E. Webber, Douglas E. Murphy, et al.. (2008). Novel HCV NS5B polymerase inhibitors derived from 4-(1′,1′-dioxo-1′,4′-dihydro-1′λ6-benzo[1′,2′,4′]thiadiazin-3′-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 1: Exploration of 7′-substitution of benzothiadiazine. Bioorganic & Medicinal Chemistry Letters. 18(4). 1413–1418. 26 indexed citations

Lira, Ricardo, Alan X. Xiang, Konstantinos A. Agrios, et al.. (2007). Syntheses of novel myxopyronin B analogs as potential inhibitors of bacterial RNA polymerase. Bioorganic & Medicinal Chemistry Letters. 17(24). 6797–6800. 25 indexed citations

LI, L, S. E. Webber, Peter S. Dragovich, et al.. (2007). Potent HCV NS5B Polymerase Inhibitors Derived From 5-Hydroxy-3(2H)-Pyridazinones: Part 1Exploration of Pyridazinone 4-Substituent Variation. Antiviral Research. 74(3). A38–A38. 3 indexed citations

10.

Xiang, Alan X., Ricardo Lira, Konstantinos A. Agrios, et al.. (2004). Myxopyronin B analogs as inhibitors of RNA polymerase, synthesis and biological evaluation. Bioorganic & Medicinal Chemistry Letters. 14(22). 5667–5672. 27 indexed citations

11.

Kissinger, Charles R., Paul A. Rejto, Laura A. Pelletier, et al.. (2004). Crystal Structure of Human ABAD/HSD10 with a Bound Inhibitor: Implications for Design of Alzheimer's Disease Therapeutics. Journal of Molecular Biology. 342(3). 943–952. 82 indexed citations

12.

McTigue, Michele, John Wickersham, Richard E. Showalter, et al.. (1999). Crystal structure of the kinase domain of human vascular endothelial growth factor receptor 2: a key enzyme in angiogenesis. Structure. 7(3). 319–330. 161 indexed citations

13.

Garcı́a-Cózar, Francisco, Heidi Okamura, J. Aramburu, et al.. (1998). Two-site Interaction of Nuclear Factor of Activated T Cells with Activated Calcineurin. Journal of Biological Chemistry. 273(37). 23877–23883. 86 indexed citations

14.

Dragovich, Peter S., Vincent J. Kalish, Charles R. Kissinger, et al.. (1996). Structure-Based Design of Novel, Urea-Containing FKBP12 Inhibitors. Journal of Medicinal Chemistry. 39(9). 1872–1884. 49 indexed citations

15.

Babine, Robert E., Ethel S. Littlefield, Hans E. Parge, et al.. (1996). Design, synthesis and X-ray crystallographic studies of [7.3.1] and [8.3.1] macrocyclic FKBP-12 ligands. Bioorganic & Medicinal Chemistry Letters. 6(4). 385–390. 8 indexed citations

16.

Tatlock, John H., Vincent J. Kalish, Hans E. Parge, et al.. (1995). High-affinity FKBP-12 ligands derived from (R)-(−)-carvone. Synthesis and evaluation of FK506 pyranose ring replacements. Bioorganic & Medicinal Chemistry Letters. 5(21). 2489–2494. 8 indexed citations

17.

Kissinger, Charles R., Hans E. Parge, Daniel R. Knighton, et al.. (1995). Crystal structures of human calcineurin and the human FKBP12–FK506–calcineurin complex. Nature. 378(6557). 641–644. 630 indexed citations breakdown →

18.

Bassler, Bonnie L., et al.. (1993). Intercellular signalling in Vibrio harveyi: sequence and function of genes regulating expression of luminescence. Molecular Microbiology. 9(4). 773–786. 603 indexed citations breakdown →

19.

McCarter, Linda L., Richard E. Showalter, & M. Silverman. (1992). Genetic analysis of surface sensing inVibrio parahaemolyticus. Biofouling. 5(3). 163–175. 13 indexed citations

20.

Showalter, Richard E., et al.. (1990). Nucleotide sequence of a gene, hpt, for hypoxanthine phosphoribosyltransferase from Vibrio harveyi. Nucleic Acids Research. 18(15). 4621–4621. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact